{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:27:56Z","timestamp":1778758076943,"version":"3.51.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07042-9","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:47:04Z","timestamp":1777866424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review"],"prefix":"10.1007","volume":"105","author":[{"given":"Pasquale","family":"Niscola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Gianfelici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"7042_CR1","doi-asserted-by":"publisher","unstructured":"Bewersdorf JP, Mina A, Stahl M, Zeidan AM (2026) A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions. Nat Rev Clin Oncol 14. https:\/\/doi.org\/10.1038\/s41571-026-01141-2","DOI":"10.1038\/s41571-026-01141-2"},{"issue":"6","key":"7042_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/biom15060761","volume":"15","author":"X Li","year":"2025","unstructured":"Li X, Zou C, Xiang X, Zhao L, Chen M, Yang C, Wu Y (2025) Myelodysplastic neoplasms (MDS): pathogenesis and therapeutic prospects. Biomolecules 15(6):761. https:\/\/doi.org\/10.3390\/biom15060761","journal-title":"Biomolecules"},{"issue":"3","key":"7042_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030508","volume":"17","author":"N Thalambedu","year":"2025","unstructured":"Thalambedu N, Mohan Lal B, Harbaugh B, Alapat DV, Gaddam M, Gentile Sanchez CG et al (2025) Unveiling myelodysplastic syndromes: exploring pathogenic mechanisms and therapeutic advances. Cancers (Basel) 17(3):508. https:\/\/doi.org\/10.3390\/cancers17030508","journal-title":"Cancers (Basel)"},{"issue":"7","key":"7042_CR4","first-page":"2157","volume":"109","author":"AG Jain","year":"2024","unstructured":"Jain AG, Ball S, Aguirre L, Al Ali N, Kaldas D, Tinsley-Vance S (2024) Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia. Haematologica 109(7):2157\u20132164","journal-title":"Haematologica"},{"issue":"3","key":"7042_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.70065","volume":"18","author":"S Xie","year":"2025","unstructured":"Xie S, Yan J, Tse P, Humphries B, Xie F (2025) Burden of myelodysplastic syndromes: a literature review of epidemiological and humanistic aspects. J Evid Based Med 18(3):e70065. https:\/\/doi.org\/10.1111\/jebm.70065","journal-title":"J Evid Based Med"},{"issue":"9","key":"7042_CR6","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1007\/s00277-025-06374-2","volume":"104","author":"X Chen","year":"2025","unstructured":"Chen X, Shukla M, Choi JH (2025) An unconquered challenge in MDS: review of pathophysiology, clinical manifestations, and management options of MDS with thrombocytopenia. Ann Hematol 104(9):4319\u20134332","journal-title":"Ann Hematol"},{"issue":"15","key":"7042_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1182\/blood.2023023727","volume":"144","author":"E Bernard","year":"2024","unstructured":"Bernard E, Hasserjian RP, Greenberg PL, Arango Ossa JE, Creignou M, Tuechler H, Guti\u00e9rrez-Abril J, Domenico D, Medina-Mart\u00ednez JS, Levine M et al (2024) Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood 144(15):1617\u20131632","journal-title":"Blood"},{"issue":"11","key":"7042_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1200\/JCO.20.01659","volume":"39","author":"M Bersanelli","year":"2021","unstructured":"Bersanelli M, Travaglino E, Meggendorfer M, Matteuzzi T, Sala C, Mosca E et al (2021) Classification and Personalized Prognostic Assessment based on Clinical and Genomic Features in Myelodysplastic Syndromes. J Clin Oncol 39(11):1223\u20131233","journal-title":"J Clin Oncol"},{"issue":"1","key":"7042_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1182\/hematology.2025000768","volume":"2025","author":"HE Carraway","year":"2025","unstructured":"Carraway HE (2025) Updates in low\/intermediate-risk MDS. Hematol Am Soc Hematol Educ Program 2025(1):699\u2013708","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"7042_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200008","volume":"1","author":"E Bernard","year":"2022","unstructured":"Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y et al (2022) Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 1(7):EVIDoa2200008. https:\/\/doi.org\/10.1056\/EVIDoa2200008","journal-title":"NEJM Evid"},{"key":"7042_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2025.107718","volume":"154","author":"L Steiner","year":"2025","unstructured":"Steiner L, Kaur N, Jann JC, Fabarius A, Metzgeroth G, Meggendorfer M et al (2025) Inter-modality variance of blast quantification in patients with myelodysplastic neoplasms (MDS) and its impact on risk stratification and overall survival. Leuk Res 154:107718. https:\/\/doi.org\/10.1016\/j.leukres.2025.107718","journal-title":"Leuk Res"},{"issue":"7","key":"7042_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"11","key":"7042_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228","journal-title":"Blood"},{"issue":"4","key":"7042_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40487-024-00303-5","volume":"12","author":"K Lewis","year":"2024","unstructured":"Lewis K, Williamson M, Brown E, Trenholm E, Hogea C (2024) Real-world study of the burden of myelodysplastic syndromes in patients and their caregivers in Europe and the United States. Oncol Ther 12(4):753\u2013774","journal-title":"Oncol Ther"},{"key":"7042_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/PROM.S346434","volume":"13","author":"J Soper","year":"2022","unstructured":"Soper J, Sadek I, Urniasz-Lippel A, Norton D, Ness M, Mesa R (2022) Patient and caregiver insights into the disease burden of myelodysplastic syndrome. Patient Relat Outcome Meas 13:31\u201338","journal-title":"Patient Relat Outcome Meas"},{"issue":"9","key":"7042_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091587","volume":"17","author":"E Cris\u00e0","year":"2025","unstructured":"Cris\u00e0 E, Cilloni D, Riva M, Balleari E, Barraco D, Manghisi B et al (2025) Unmet needs and their impact on quality of life and symptoms in myelodysplastic neoplasm patients and caregivers. Cancers (Basel) 17(9):1587. https:\/\/doi.org\/10.3390\/cancers17091587","journal-title":"Cancers (Basel)"},{"key":"7042_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002865","volume":"26","author":"AV Desai","year":"2021","unstructured":"Desai AV, Klimek VM, Wan PJ, Heinberg A, Anderson KL, Bernal C et al (2021) Palliative medicine in myelodysplastic syndromes: patients and caregivers - a qualitative study. BMJ Support Palliat Care 26:bmjspcare-2020-002865. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002865","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"7042_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12904-025-01811-5","volume":"24","author":"RR Pai","year":"2025","unstructured":"Pai RR, Ghoshal A, Udupa K, Pai A, Mailankody S, Damani A (2025) Assessing palliative care needs in adult patients with hematological malignancies and their caregivers: implications for referral practice. BMC Palliat Care 24(1):201. https:\/\/doi.org\/10.1186\/s12904-025-01811-5","journal-title":"BMC Palliat Care"},{"issue":"1","key":"7042_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-025-01712-7","volume":"24","author":"CE Kircher","year":"2025","unstructured":"Kircher CE, Hanna TP, Tranmer J, Goldie CE, Ross-White A, Moulton E et al (2025) Defining \u201cearly palliative care\u201d for adults diagnosed with a life-limiting illness: a scoping review. BMC Palliat Care 24(1):93. https:\/\/doi.org\/10.1186\/s12904-025-01712-7","journal-title":"BMC Palliat Care"},{"issue":"1","key":"7042_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjh.18286","volume":"199","author":"A Shaulov","year":"2022","unstructured":"Shaulov A, Aviv A, Alcalde J, Zimmermann C (2022) Early integration of palliative care for patients with haematological malignancies. Br J Haematol 199(1):14\u201330","journal-title":"Br J Haematol"},{"issue":"2","key":"7042_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/spcare-2024-004812","volume":"14","author":"L Potenza","year":"2024","unstructured":"Potenza L, Luppi M, Zimmermann C, Bandieri E (2024) Early palliative care in haematological malignancies. BMJ Support Palliat Care 14(2):230\u2013232","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"7042_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpainsymman.2025.03.029","volume":"70","author":"L Potenza","year":"2025","unstructured":"Potenza L, Giusti D, Borelli E, Colaci E, Banchelli F, Cuoghi Costantini R et al (2025) Early Palliative Care, Goals of Care Conversations, and Quality EOL Care in Acute Leukemia and HR-MDS. J Pain Symptom Manage 70(2):121\u2013130","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"7042_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11864-023-01084-1","volume":"24","author":"GA Robbins-Welty","year":"2023","unstructured":"Robbins-Welty GA, Webb JA, Shalev D, El-Jawahri A, Jackson V, Mitchell C et al (2023) Advancing palliative care integration in hematology: building upon existing evidence. Curr Treat Options Oncol 24(5):542\u2013564","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"7042_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041047","volume":"14","author":"D Hui","year":"2022","unstructured":"Hui D, Heung Y, Bruera E (2022) Timely palliative care: personalizing the process of referral. Cancers (Basel) 14(4):1047. https:\/\/doi.org\/10.3390\/cancers14041047","journal-title":"Cancers (Basel)"},{"issue":"6","key":"7042_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1200\/OP.24.00081","volume":"20","author":"M Tsang","year":"2024","unstructured":"Tsang M, LeBlanc TW (2024) Palliative and end-of-life care in hematologic malignancies: progress and opportunities. JCO Oncol Pract 20(6):739\u2013741","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"7042_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11899-016-0352-z","volume":"11","author":"M Nickolich","year":"2016","unstructured":"Nickolich M, El-Jawahri A, LeBlanc TW (2016) Palliative and end-of-life care in myelodysplastic syndromes. Curr Hematol Malig Rep 11(6):434\u2013440","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"7042_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1200\/JCO.18.02386","volume":"38","author":"A El-Jawahri","year":"2020","unstructured":"El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW (2020) Palliative and end-of-life care for patients with hematologic malignancies. J Clin Oncol 38(9):944\u2013953","journal-title":"J Clin Oncol"},{"key":"7042_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/10499091261416032","volume":"8","author":"OM Seecof","year":"2026","unstructured":"Seecof OM (2026) Advance care planning for patients with hematologic malignancies: a narrative review. Am J Hosp Palliat Care 8:10499091261416032. https:\/\/doi.org\/10.1177\/10499091261416032","journal-title":"Am J Hosp Palliat Care"},{"key":"7042_CR29","doi-asserted-by":"crossref","unstructured":"Locastro M, Wang Y, Baran AM, Mortaz Hedjri S, Frumusa D, Natale T et al (2026) An inpatient serious illness care program for older patients with hematologic malignancies: a single-arm pilot study. Blood Adv. 8:bloodadvances. 2025018200","DOI":"10.1182\/bloodadvances.2025018200"},{"issue":"4","key":"7042_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21037\/apm-25-32","volume":"14","author":"P Niscola","year":"2025","unstructured":"Niscola P, Piccioni D, Giovannini M (2025) Palliative care interventions and their early integration in the management of older adults with acute myeloid leukemia: a narrative review. Ann Palliat Med 14(4):393\u2013411","journal-title":"Ann Palliat Med"},{"issue":"10","key":"7042_CR31","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.21037\/apm-22-691","volume":"11","author":"KY Chan","year":"2022","unstructured":"Chan KY, Chan TSY, Gill H, Chan TCW, Li CW, Au HY et al (2022) Supportive care and symptom management in patients with advanced hematological malignancies: a literature review. Ann Palliat Med 11(10):3273\u20133291","journal-title":"Ann Palliat Med"},{"key":"7042_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2147\/CMAR.S482570","volume":"17","author":"MC Maravic","year":"2025","unstructured":"Maravic MC, Land N, Prood N, Cagle C, May SG, Batt K et al (2025) Experiences with Higher-Risk Myelodysplastic Syndromes and Improving Patient-Centered Treatment Decision-Making: A Qualitative Study of Patients, Caregivers, and Providers. Cancer Manag Res 17:1215\u20131232","journal-title":"Cancer Manag Res"},{"issue":"8","key":"7042_CR33","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10198-025-01779-2","volume":"26","author":"P Tse","year":"2025","unstructured":"Tse P, Xie S, Yan J, Humphries B, Xie F (2025) Burden of myelodysplastic syndromes: a systematic literature review of economic burden. Eur J Health Econ 26(8):1469\u20131485","journal-title":"Eur J Health Econ"},{"issue":"3","key":"7042_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030478","volume":"14","author":"L Potenza","year":"2022","unstructured":"Potenza L, Borelli E, Bigi S, Giusti D, Longo G, Odejide O et al (2022) Early palliative care in acute myeloid leukemia. Cancers (Basel) 14(3):478. https:\/\/doi.org\/10.3390\/cancers14030478","journal-title":"Cancers (Basel)"},{"issue":"3","key":"7042_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.6004\/jnccn.2017.7048","volume":"16","author":"JD Troy","year":"2018","unstructured":"Troy JD, de Castro CM, Pupa MR, Samsa GP, Abernethy AP, LeBlanc TW (2018) Patient-reported distress in Myelodysplastic Syndromes and its association with clinical outcomes: a retrospective cohort study. J Natl Compr Canc Netw 16(3):267\u2013273","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"7042_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12325-022-02277-0","volume":"40","author":"PP Frank","year":"2023","unstructured":"Frank PP, Lu MXE, Sasse EC (2023) Educational and emotional needs of patients with Myelodysplastic Syndromes: an AI analysis of multi-country social media. Adv Ther 40(1):159\u2013173","journal-title":"Adv Ther"},{"key":"7042_CR37","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S1478951525101582","volume":"24","author":"HE Hoffst\u00e4dt","year":"2026","unstructured":"Hoffst\u00e4dt HE, Stoppelenburg A, Tam MC, Hartog ID, van Bodegom-Vos L, Mertens BJA et al (2026) Improving support for family caregivers: A mixed-methods effect evaluation of an organizational intervention. Palliat Support Care 24:e39","journal-title":"Palliat Support Care"},{"issue":"1","key":"7042_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpainsymman.2017.08.030","volume":"55","author":"MJ Hochman","year":"2018","unstructured":"Hochman MJ, Yu Y, Wolf SP, Samsa GP, Kamal AH, LeBlanc TW (2018) Comparing the palliative care needs of patients with hematologic and solid malignancies. J Pain Symptom Manage 55(1):82\u201388","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"7042_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.htct.2022.07.006","volume":"45","author":"APS Ferreira","year":"2023","unstructured":"Ferreira APS, Ferraz LFM, de Melo Campos P, Teixeira PMN (2023) There\u2019s nothing left to do! the interface between hematology and palliative care. Hematol Transfus Cell Ther 45(1):134\u2013136","journal-title":"Hematol Transfus Cell Ther"},{"issue":"21","key":"7042_CR40","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.3390\/healthcare13212789","volume":"13","author":"P Fernandes-Almeida","year":"2025","unstructured":"Fernandes-Almeida P, Reis-Pina P (2025) Early palliative care in advanced hematologic malignancies: a systematic review of patient-centered outcomes. Healthc (Basel) 13(21):2789. https:\/\/doi.org\/10.3390\/healthcare13212789","journal-title":"Healthc (Basel)"},{"issue":"9","key":"7042_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/17474086.2022.2121696","volume":"15","author":"N Kayastha","year":"2022","unstructured":"Kayastha N, LeBlanc TW (2022) Palliative care for patients with hematologic malignancies: are we meeting patients\u2019 needs early enough? Expert Rev Hematol 15(9):813\u2013820","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"7042_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/jpm.2010.0347","volume":"14","author":"DE Weissman","year":"2011","unstructured":"Weissman DE, Meier DE (2011) Identifying patients in need of a palliative care assessment in the hospital setting: a consensus report from the Center to Advance Palliative Care. J Palliat Med 14(1):17\u201323","journal-title":"J Palliat Med"},{"issue":"8","key":"7042_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1200\/JCO.2011.38.5161","volume":"30","author":"TJ Smith","year":"2012","unstructured":"Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880\u2013887","journal-title":"J Clin Oncol"},{"issue":"19","key":"7042_CR44","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1200\/JCO.24.00542","volume":"42","author":"JJ Sanders","year":"2024","unstructured":"Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C et al (2024) Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol 42(19):2336\u20132357","journal-title":"J Clin Oncol"},{"key":"7042_CR45","doi-asserted-by":"crossref","unstructured":"Dans M, Kutner JS, Agarwal R, Baker JN, Bauman JR, Beck AC et al (2021) NCCN guidelines\u00ae insights: palliative care, Version 2.2021. J Natl Compr Canc Netw. 19(7):780\u2013788","DOI":"10.6004\/jnccn.2021.0033"},{"issue":"2","key":"7042_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","volume":"32","author":"P Fenaux","year":"2021","unstructured":"Fenaux P, Haase D, Santini V, Sanz GF, Platzbecker U, Mey U (2021) Myelodysplastic syndromes: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(2):142\u2013156","journal-title":"Ann Oncol"},{"issue":"3","key":"7042_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.6004\/jnccn.2025.0013","volume":"23","author":"PL Greenberg","year":"2025","unstructured":"Greenberg PL, Stone RM, Abaza Y, Al-Kali A, Anand S, Ball B et al (2025) NCCN Guidelines\u00ae Insights: Myelodysplastic Syndromes, Version 2.2025. J Natl Compr Canc Netw 23(3):66\u201375","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"7042_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jpm.2019.0349","volume":"23","author":"NC Ernecoff","year":"2020","unstructured":"Ernecoff NC, Check D, Bannon M, Hanson LC, Dionne-Odom JN, Corbelli J et al (2020) Comparing specialty and primary palliative care interventions: analysis of a systematic review. J Palliat Med 23(3):389\u2013396","journal-title":"J Palliat Med"},{"issue":"4","key":"7042_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jpainsymman.2021.03.014","volume":"62","author":"E Elliott","year":"2021","unstructured":"Elliott E, Watson T, Singh D, Wong C, Lo SS (2021) Outcomes of specialty palliative care interventions for patients with hematologic malignancies: a systematic review. J Pain Symptom Manage 62(4):863\u2013875","journal-title":"J Pain Symptom Manage"},{"key":"7042_CR50","doi-asserted-by":"publisher","unstructured":"Jin H, Guo Z, Zhu L, Huang F, Wu Y, Qiu H et al (2025) Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis. Br J Haematol https:\/\/doi.org\/10.1111\/bjh.70284","DOI":"10.1111\/bjh.70284"},{"key":"7042_CR51","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F et al (2012) Revised International Prognostic Scoring System for myelodysplastic syndromes. Blood 120:2454\u20132465","journal-title":"Blood"},{"issue":"1","key":"7042_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-020-00556-7","volume":"19","author":"M Bennardi","year":"2020","unstructured":"Bennardi M, Diviani N, Gamondi C, St\u00fcssi G, Saletti P, Cinesi I et al (2020) Palliative care utilization in oncology and hemato-oncology: a systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult patients, and their families. BMC Palliat Care 19(1):47. https:\/\/doi.org\/10.1186\/s12904-020-00556-7","journal-title":"BMC Palliat Care"},{"issue":"10","key":"7042_CR53","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1007\/s00277-025-06594-6","volume":"104","author":"L Potenza","year":"2025","unstructured":"Potenza L, Efficace F, Borelli E, Fazi P, Baldi T, Tartaglia F (2025) Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA survey. Ann Hematol 104(10):5423\u20135432","journal-title":"Ann Hematol"},{"key":"7042_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2021-002898","volume":"8","author":"L Potenza","year":"2021","unstructured":"Potenza L, Scaravaglio M, Fortuna D, Giusti D, Colaci E, Pioli V et al (2021) Early palliative\/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: observational outpatient study. BMJ Support Palliat Care 8:bmjspcare-2021-002898. https:\/\/doi.org\/10.1136\/bmjspcare-2021-002898","journal-title":"BMJ Support Palliat Care"},{"key":"7042_CR55","doi-asserted-by":"publisher","unstructured":"Facchinelli D, Greco C, Rigno M, Menon D, Manno P, Potenza L et al (2025) Palliative care is related to less aggressive end-of-life treatment in hematology-oncology: a retrospective cohort study. BMJ Support Palliat Care 18(spcare\u20132024\u2013005089). https:\/\/doi.org\/10.1136\/spcare-2024-005089","DOI":"10.1136\/spcare-2024-005089"},{"issue":"8","key":"7042_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081563","volume":"16","author":"P Niscola","year":"2024","unstructured":"Niscola P, Gianfelici V, Giovannini M, Piccioni D, Mazzone C, de Fabritiis P (2024) Latest insights and therapeutic advances in myelodysplastic neoplasms. Cancers (Basel) 16(8):1563","journal-title":"Cancers (Basel)"},{"issue":"10","key":"7042_CR57","volume":"16","author":"HR Alsuliman","year":"2024","unstructured":"Alsuliman HR, Alsaigh SA, Habib FA, Alshehery MZ (2024) Exploring the influence of the Edmonton symptom assessment system implementation in palliative care patients: a systematic review. Cureus 16(10):e70914","journal-title":"Cureus"},{"issue":"4","key":"7042_CR58","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41375-023-01831-1","volume":"37","author":"C Baer","year":"2023","unstructured":"Baer C, Huber S, Hutter S, Meggendorfer M, Nadarajah N, Walter W, Platzbecker U, G\u00f6tze KS, Kern W, Haferlach T, Hoermann G, Haferlach C et al (2023) Risk prediction in MDS: independent validation of the IPSS-M ready for routine? Leukemia 37(4):938\u2013941","journal-title":"Leukemia"},{"issue":"9","key":"7042_CR59","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1007\/s00277-025-06570-0","volume":"104","author":"F Schulz","year":"2025","unstructured":"Schulz F, Kellersmann C, Betz B, Hildebrandt B, Kasprzak A, Strupp C et al (2025) Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice. Ann Hematol 104(9):4531\u20134538","journal-title":"Ann Hematol"},{"issue":"6","key":"7042_CR60","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1007\/s00277-025-06485-w","volume":"104","author":"KA Rauhe","year":"2025","unstructured":"Rauhe KA, Kasprzak A, Schulz F, Nachtkamp K, Strupp C, K\u00fcndgen A (2025) Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis. Ann Hematol 104(6):3281\u20133288","journal-title":"Ann Hematol"},{"issue":"9","key":"7042_CR61","first-page":"814","volume":"33","author":"CB Myrh\u00f8j","year":"2025","unstructured":"Myrh\u00f8j CB, Bernacki R, Bjerre-Bertelsen S, Jacobsen J, Klintman J, Jarden M et al (2025) Serious illness conversations and quality of end-of-life care in patients with hematological malignancies-a retrospective quality improvement study. Support Care Cancer 33(9):814","journal-title":"Support Care Cancer"},{"issue":"1","key":"7042_CR62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/hematology.2021000277","volume":"2021","author":"AE DeZern","year":"2021","unstructured":"DeZern AE (2021) Lower risk but high risk. Hematol Am Soc Hematol Educ Program 2021(1):428\u2013434","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"7042_CR63","first-page":"330","volume":"110","author":"AMA Merz","year":"2025","unstructured":"Merz AMA, Platzbecker U (2025) Treatment of lower-risk myelodysplastic syndromes. Haematologica 110(2):330\u2013338","journal-title":"Haematologica"},{"issue":"10","key":"7042_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ajh.25234","volume":"93","author":"CB Benton","year":"2018","unstructured":"Benton CB, Khan M, Sallman D, Nazha A, Nogueras Gonz\u00e1lez GM, Piao J et al (2018) Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R. Am J Hematol 93(10):1245\u20131253","journal-title":"Am J Hematol"},{"issue":"9","key":"7042_CR65","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.clml.2024.03.006","volume":"24","author":"MJ Hochman","year":"2024","unstructured":"Hochman MJ, DeZern AE (2024) SOHO state of the art updates and next questions: an update on higher risk myelodysplastic syndromes. Clin Lymphoma Myeloma Leuk 24(9):573\u2013582","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"7042_CR66","first-page":"339","volume":"110","author":"N Kr\u00f6ger","year":"2025","unstructured":"Kr\u00f6ger N (2025) Treatment of high-risk myelodysplastic syndromes. Haematologica 110(2):339\u2013349","journal-title":"Haematologica"},{"issue":"15","key":"7042_CR67","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S1470-2045(15)00206-5","volume":"16","author":"F Efficace","year":"2015","unstructured":"Efficace F, Gaidano G, Breccia M, Voso MT, Cottone F, Angelucci E et al (2015) Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. Lancet Oncol 16(15):1506\u20131514","journal-title":"Lancet Oncol"},{"issue":"12","key":"7042_CR68","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1007\/s00277-024-06096-x","volume":"103","author":"S Mathur","year":"2024","unstructured":"Mathur S, Christou G, Delage R, Elemary M, Finn N, Geddes M et al (2024) Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry. Ann Hematol 103(12):5241\u20135248","journal-title":"Ann Hematol"},{"issue":"11","key":"7042_CR69","doi-asserted-by":"publisher","first-page":"e9cyto33","DOI":"10.1016\/j.clml.2025.06.009","volume":"25","author":"M D\u2019Aveni","year":"2025","unstructured":"D\u2019Aveni M, Fernandes J, Chartier M, Cott\u00e9 FE, Pag\u00e8s N, Panes A et al (2025) Incidence and burden of lower-risk myelodysplastic syndrome: a nationwide population study. Clin Lymphoma Myeloma Leuk 25(11):e9cyto33-e941.e2","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"7042_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00520-026-10429-z","volume":"34","author":"A Holopainen","year":"2026","unstructured":"Holopainen A, Kuittinen T, Tyynel\u00e4-Korhonen K, Lamminm\u00e4ki A (2026) Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience. Support Care Cancer 34(3):241. https:\/\/doi.org\/10.1007\/s00520-026-10429-z","journal-title":"Support Care Cancer"},{"key":"7042_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2025.101301","volume":"14","author":"A Mina","year":"2025","unstructured":"Mina A, Madanat Y, Abaza Y, Zeidan AM (2025) Navigating the dynamic landscape of lower-risk MDS: advances and emerging insights. Blood Rev 14:101301. https:\/\/doi.org\/10.1016\/j.blre.2025.101301","journal-title":"Blood Rev"},{"issue":"3","key":"7042_CR72","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/10428190802714024","volume":"50","author":"C Cartoni","year":"2009","unstructured":"Cartoni C, Niscola P, Breccia M, Brunetti G, D\u2019Elia GM, Giovannini M et al (2009) Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience. Leuk Lymphoma 50(3):387\u2013391","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"7042_CR73","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s00277-025-06421-y","volume":"104","author":"N Galli","year":"2025","unstructured":"Galli N, Pettine L, Croci G, Passamonti F, Barcellini W, Fattizzo B (2025) Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes. Ann Hematol 104(6):3261\u20133269","journal-title":"Ann Hematol"},{"key":"7042_CR74","doi-asserted-by":"publisher","unstructured":"Hoff FW, Chung SS, Zeidan AM, Madanat YF (2025) Management of anemia in lower-risk myelodysplastic syndromes\/neoplasms with novel agents. JCO Oncol Pract OP2400910. https:\/\/doi.org\/10.1200\/OP-24-00910","DOI":"10.1200\/OP-24-00910"},{"issue":"9","key":"7042_CR75","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1177\/10499091241287940","volume":"42","author":"AC Short","year":"2025","unstructured":"Short AC, Kuroki M, Coombs LA (2025) Palliative care referral in adult allogeneic hematopoietic stem cell transplants: an integrative literature review. Am J Hosp Palliat Care 42(9):962\u2013970","journal-title":"Am J Hosp Palliat Care"},{"issue":"4","key":"7042_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-06981-7","volume":"105","author":"L Preuss","year":"2026","unstructured":"Preuss L, Simon ST, Herling M, Holtick U, Reimer A, Schoerger B et al (2026) How to talk about death? A cross-sectional survey on patients\u2019, informal caregivers\u2019 and health care professionals\u2019 views in the setting of allogenic hematopoietic stem cell transplantation. Ann Hematol 105(4):225. https:\/\/doi.org\/10.1007\/s00277-026-06981-7","journal-title":"Ann Hematol"},{"key":"7042_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100851","volume":"50","author":"EN Oliva","year":"2021","unstructured":"Oliva EN, Platzbecker U, Fenaux P, Garcia-Manero G, LeBlanc TW, Patel BJ et al (2021) Targeting health-related quality of life in patients with myelodysplastic syndromes - current knowledge and lessons to be learned. Blood Rev 50:100851. https:\/\/doi.org\/10.1016\/j.blre.2021.100851","journal-title":"Blood Rev"},{"issue":"10","key":"7042_CR78","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/trf.18391","volume":"65","author":"A Mo","year":"2025","unstructured":"Mo A, Wood EM, Shortt J, McQuilten ZK (2025) Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes. Transfusion 65(10):1803\u20131809","journal-title":"Transfusion"},{"issue":"2","key":"7042_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-06789-5","volume":"105","author":"S Mandal","year":"2026","unstructured":"Mandal S, Dhali A, Sil S, Maji M, Deb J, Mohan AK et al (2026) Comparison of safety and efficacy of liberal versus restrictive red blood cell transfusion thresholds on the quality of life in patients with myelodysplastic syndromes: A systematic review and meta-analysis. Ann Hematol 105(2):61. https:\/\/doi.org\/10.1007\/s00277-026-06789-5","journal-title":"Ann Hematol"},{"issue":"2","key":"7042_CR80","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1016\/S2352-3026(24)00350-8","volume":"12","author":"HKG Garelius","year":"2025","unstructured":"Garelius HKG, Bagguley T, Taylor A, Fenaux P, Bowen D et al (2025) Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study. Lancet Haematol 12(2):e128\u2013e137","journal-title":"Lancet Haematol"},{"issue":"2","key":"7042_CR81","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1016\/S2352-3026(24)00355-7","volume":"12","author":"P Niscola","year":"2025","unstructured":"Niscola P (2025) Improved survival and enhanced quality of life through anaemia correction in lower risk myelodysplastic syndromes: Meaningful insights from an EUMDS Registry study. Lancet Haematol 12(2):e88\u2013e90","journal-title":"Lancet Haematol"},{"issue":"12","key":"7042_CR82","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s00277-021-04654-1","volume":"100","author":"HJCM Wouters","year":"2021","unstructured":"Wouters HJCM, Conrads-Frank A, Koinig KA, Smith A, Yu G, de Witte T et al (2021) The anemia-independent impact of myelodysplastic syndromes on health-related quality of life. Ann Hematol 100(12):2921\u20132932","journal-title":"Ann Hematol"},{"issue":"18","key":"7042_CR83","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.3390\/jcm12185865","volume":"12","author":"Y Haring","year":"2023","unstructured":"Haring Y, Goldschmidt N, Taha S, Stemer G, Filanovsky K, Hellman I et al (2023) MDS-Related Anemia Is Associated with Impaired Quality of Life, but Improvement Is Not Always Achieved by Increased Hemoglobin Level. J Clin Med 12(18):5865","journal-title":"J Clin Med"},{"issue":"11","key":"7042_CR84","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/17474086.2023.2268837","volume":"16","author":"Z Liu","year":"2023","unstructured":"Liu Z, Xu X, Ding K, Fu R (2023) Quality of life considerations and management in patients with myelodysplastic syndrome. Expert Rev Hematol 16(11):849\u2013860","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"7042_CR85","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17474086.2024.2378035","volume":"17","author":"P Niscola","year":"2024","unstructured":"Niscola P, Gianfelici V, Giovannini M, Piccioni D, Mazzone C, de Fabritiis P (2024) Quality-of-life considerations in myelodysplastic syndrome: Not just fatigue. Expert Rev Hematol 17(8):407\u2013410","journal-title":"Expert Rev Hematol"},{"key":"7042_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2026.02.011","volume":"2","author":"S Cebeci","year":"2026","unstructured":"Cebeci S, Serra\u00e7 E, Elverdi T, Saliho\u011flu A, Ar MC, \u00d6ng\u00f6ren \u015e et al (2026) Impact of systemic inflammatory and autoimmune diseases on outcomes in patients with myelodysplastic syndrome and chronic myelomonocytic leukemia. Clin Lymphoma Myeloma Leuk 2:S2152-2650(26)00061\u2009\u2212\u20093. https:\/\/doi.org\/10.1016\/j.clml.2026.02.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"7042_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061162","volume":"10","author":"Q Scanvion","year":"2021","unstructured":"Scanvion Q, Pascal L, Sy T, Stervinou-W\u00e9meau L, Lejeune AL, Deken V et al (2021) Systemic pulmonary events associated with myelodysplastic syndromes: A retrospective multicentre study. J Clin Med 10(6):1162. https:\/\/doi.org\/10.3390\/jcm10061162","journal-title":"J Clin Med"},{"issue":"2","key":"7042_CR88","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","volume":"21","author":"MSY Thong","year":"2020","unstructured":"Thong MSY, van Noorden CJF, Steindorf K, Arndt V (2020) Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol 21(2):17. https:\/\/doi.org\/10.1007\/s11864-020-0707-5","journal-title":"Curr Treat Options Oncol"},{"key":"7042_CR89","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.leukres.2016.05.022","volume":"47","author":"MK Schuler","year":"2016","unstructured":"Schuler MK, Hentschel L, G\u00f6bel J, Balaian E, Hornemann B, Hoffmann J et al (2016) Effects of a home-based exercise program on physical capacity and fatigue in patients with low to intermediate risk myelodysplastic syndrome-a pilot study. Leuk Res 47:128\u201335","journal-title":"Leuk Res"},{"issue":"3","key":"7042_CR90","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/gps.1275","volume":"20","author":"J Ankri","year":"2025","unstructured":"Ankri J, Andrieu S, Beaufils B, Grand A, Henrard JC (2025) Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians. Int J Geriatr Psychiatry 20(3):254\u2013260","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"7042_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jpainsymman.2024.08.025","volume":"69","author":"S Hochrath","year":"2025","unstructured":"Hochrath S, Dhollander N, Deliens L, Schots R, Daenen F, Kerre T et al (2025) Palliative care in hematology: a systematic review of the components, effectiveness, and implementation. J Pain Symptom Manage 69(1):114\u2013133","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"7042_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy13060167","volume":"13","author":"I Samard\u017ei\u0107","year":"2025","unstructured":"Samard\u017ei\u0107 I, Marinovi\u0107 I, Marovi\u0107 I, Ku\u010da N, Ba\u010di\u0107 Vrca V (2025) Pharmacist intervention models in drug-drug interaction management in prescribed pharmacotherapy. Pharmacy Basel 13(6):167. https:\/\/doi.org\/10.3390\/pharmacy13060167","journal-title":"Pharmacy Basel"},{"issue":"6","key":"7042_CR93","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1089\/jpm.2020.0396","volume":"24","author":"C Cartoni","year":"2021","unstructured":"Cartoni C, Breccia M, Giesinger JM, Baldacci E, Carmosino I, Annechini G et al (2021) Early palliative home care versus hospital care for patients with hematologic malignancies: a cost-effectiveness study. J Palliat Med 24(6):887\u2013893","journal-title":"J Palliat Med"},{"issue":"6","key":"7042_CR94","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1200\/OP-24-00556","volume":"21","author":"M LoCastro","year":"2025","unstructured":"LoCastro M, Baran A, Liesveld J, Huselton E, Hill E, Loh KP et al (2025) Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes. JCO Oncol Pract 21(6):876\u2013882","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"7042_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jpainsymman.2023.10.024","volume":"67","author":"MJ Pisarcik","year":"2024","unstructured":"Pisarcik MJ, LeBlanc TW (2024) Overcoming transfusion needs as a barrier to hospice care for patients with blood cancers. J Pain Symptom Manage 67(1):10\u201311","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"7042_CR96","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1182\/hematology.2024000560","volume":"2024","author":"R Rodenbach","year":"2024","unstructured":"Rodenbach R, Caprio T, Loh KP (2024) Challenges in hospice and end-of-life care in the transfusion-dependent patient. Hematol Am Soc Hematol Educ Program 2024(1):340\u2013347","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"7042_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-019-0458-x","volume":"18","author":"J Pieters","year":"2019","unstructured":"Pieters J, Dolmans DHJM, Verstegen DML, Warmenhoven FC, Courtens AM, van den Beuken-van Everdingen MHJ (2019) Palliative care education in the undergraduate medical curricula: students\u2019 views on the importance of, their confidence in, and knowledge of palliative care. BMC Palliat Care 18(1):72. https:\/\/doi.org\/10.1186\/s12904-019-0458-x","journal-title":"BMC Palliat Care"},{"key":"7042_CR98","first-page":"1","volume":"21","author":"P Niscola","year":"2025","unstructured":"Niscola P, Piccioni D, Giovannini M (2025) Early palliative care in older patients with acute myeloid leukemia undergoing novel therapies. Expert Rev Hematol Dec 21:1\u20135","journal-title":"Expert Rev Hematol Dec"},{"issue":"4","key":"7042_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040835","volume":"13","author":"F Stagno","year":"2025","unstructured":"Stagno F, Mirabile G, Rizzotti P, Bottaro A, Pagana A, Gangemi S et al (2025) Using artificial intelligence to enhance myelodysplastic syndrome diagnosis, prognosis, and treatment. Biomedicines 13(4):835. https:\/\/doi.org\/10.3390\/biomedicines13040835","journal-title":"Biomedicines"},{"issue":"2","key":"7042_CR100","first-page":"216","volume":"27","author":"S Payne","year":"2024","unstructured":"Payne S, Begovic D, Salifu Y, Nelson A, Payne C, Downing J et al (2024) Applying Digital Health in Cancer and Palliative Care in Europe: Policy Recommendations from an International Expert Workshop (MyPal Project). J Palliat Med 27(2):216\u2013223","journal-title":"J Palliat Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07042-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:03:46Z","timestamp":1778756626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07042-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":100,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7042"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07042-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}